Organizing Committee
Connecting Minds, Pushing Boundaries
16 – 18 December 2021, Sofitel Dubai The Obelisk, Dubai, UAE
Connecting Minds, Pushing Boundaries
16 – 18 December 2021, Sofitel Dubai The Obelisk, Dubai, UAE
Consultant, Anatomic Pathologist & Cytopathologist
Medical Director, e-Pathology Program
Clinical Professor of Pathology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland Clinic Abu Dhabi
UAE
Dr. Nahal is a Staff Physician and consultant anatomic pathologist and cytopathologist in the Pathology & Laboratory Medicine Institute at Cleveland Clinic Abu Dhabi/National Reference Laboratory. His main interests and expertise include the interpretation of biopsy and resection specimens in the fields of soft tissue and bone tumor pathology, genitourinary pathology, cytopathology and has special interest in digital pathology. In cytopathology, his expertise include the cytologic diagnosis of thyroid nodules and endoscopic ultrasound guided fine needle aspirations of pancreatic solid and cystic tumors.
Prior to joining Cleveland Clinic Abu Dhabi in 2014, Dr. Ayoub Nahal has had 12 years’ working experience in Anatomic Pathology from McGill University Health Center in Montreal, Canada. At McGill University, he also held an academic appointment of Associate Professor at the Faculty of Medicine where he was a regular lecturer. He specialized in Cytopathology, and in Soft tissue and bone tumor Pathology where he had a consultation service providing expert opinion on cases received from the entire province of Quebec. He holds two American Board Certifications both in Anatomic Pathology and Cytopathology. He also obtained the American Board of Lifestyle Medicine in 2020.
He received his pathology residency at St Vincent’s Hospital and Medical Center of New York, followed by three fellowships, two of which obtained from Hartford Hospital, Connecticut in General Surgical Pathology and Cytopathology respectively, and a third fellowship in Oncologic Pathology at Memorial Sloan Kettering Cancer Center in New York City.
At Cleveland Clinic Abu Dhabi, he established the ePathology (digital Pathology) program, the first in the United Arab Emirates, to be used for rapid response digital pathology consultation services with the main campus at Cleveland Clinic, and to be integrated in a range of educational and laboratory applications at Cleveland Clinic Abu Dhabi.
He also acts as an expert consultant in bone and soft tissue tumor pathology for various Pathology departments and laboratories in the UAE. He is an active member at the International Skeletal Society and The International Society of Bone and Soft tissue Pathology, in addition to being member at The Memorial Hospital Alumni Society, College of American Pathologists (CAP), and The Canadian Association of Pathologists. He is a reviewer for the Skeletal Radiology Journal and Cancer Cytopathology. He is also an adjunct faculty at Khalifa University School of Medicine. He has lectured at numerous meetings in Canada and currently in the UAE and has over 45 publications in peer-reviewed journals, mostly in Bone and Soft tissue tumor pathology.
Department of Pathology & Translational Genomics
Samsung Medical Center
Sungkyunkwan University School of Medicine
Seoul, Korea
Head and Senior Consultant
Department of Anatomical Pathology
Singapore General Hospital
Singapore
Prof Tony Lim leads the Department of Anatomical Pathology in Singapore General Hospital. His research interests include molecular genetics, personalised medicine and the study of lung, liver and gastrointestinal diseases. As the Head of Section of Translational Pathology Centre and the Clinical Director of Personalised OMIC Lattice for Advanced Research and Improving Stratification (POLARIS@GIS), Prof Lim collaborates with many industry and non-industry partners, contributing his clinical expertise to numerous research projects leading to new developments and findings published in many peer-reviewed journals. Prof Lim is currently the Academic Vice-chair (Strategic Programmes) in the Pathology Academic Clinical Programme, and directs many research initiatives which are instrumental in translating discovery into diagnostics.
Chair Translational Nephropathology (Heisenberg Professor)
Head of Electron Microscopy Facility
Senior Physician, RWTH Lecturer
University Hospital, RWTH Aachen
Germany
Professor Peter Boor received his medical and scientific training at the Medical Schools of Bratislava in Slovakia and Aachen Germany. Peter Boor is a senior consultant pathologist, Heisenberg Professor and chair of Translational Nephropathology, Electron Microscopy Facility and Digital Pathology at the University Clinic Aachen. He is the RWTH Lecturer and received prizes for excellent teaching of medical students. He is a member of several national and international societies of pathology, renal pathology and nephrology and he received several prestigious awards from these societies. His group, the LaBooratory of Nephropathology, focuses on diagnostic biomarkers with particular focus on imaging, digital pathology and AI, as well as in vivo animal modeling, and understanding of pathological processes in CKD, fibrosis and vasculature. His scientific work encompasses about 200 original papers, reviews and editorials, and several book chapters.
Professor
The University of Texas M.D Anderson Cancer Center
USA
Dr. Preetha Ramalingam received her medical degree from Rajah Muthiah Medical College (India). She completed her AP/CP training at Henry Ford Hospital, Detroit, MI and at Cleveland Clinic Foundation, Cleveland, OH. She then did a Selective Pathology Fellowship at UT MD Anderson Cancer Center, Houston, TX and a Hematopathology Fellowship at University of Michigan, Ann Arbor, MI. She is board certified in Anatomic and Clinical Pathology and Hematology by the American Board of Pathology. Dr Preetha worked at the Medical College of Georgia (2003-2010) prior to joining UT MD Anderson Cancer Center as Associate Professor of Pathology in the Section of Gynecologic Pathology in 2011 and is currently Professor of Pathology and have over 10 years of experience in subspecialized gynecologic oncology practice and have authored several papers in this field. She has presented at several national and international conferences on gynecologic pathology. Her research interests are focused on ovarian cancer and undifferentiated endometrial carcinoma. In addition to clinical service and research she is also the Director of the Gynecologic Pathology Fellowship Program.
President of Emirates Pathology Society
President of Emirates Medical Association
Head of Pathology, Dubai Hospital
UAE
General Secretary of Emirates Pathology Society
Consultant Anatomic Pathologist
Head of Histology, Dubai Hospital
UAE
Cultural Committee Chairperson of Emirates Pathology Society
Consultant Anatomic Pathologist, H.H. Sheikh Khalifa Specialty Hospital
UAE
MD, PhD, FCAP
Vice-President of Emirates Pathology Society
Consultant Anatomic Pathologist,
King's College Hospital Dubai, United Arab Emirates
Deputy International Commissioner for UAE, College of American Pathologists
Visiting Professor, Mohammed bin Rashid University School of Medicine UAE
MPhil, MD, FCAP
Scientific Committee Chairperson of Emirates Pathology Society,
Group Head of Pathology and Laboratory Services,
VPS Healthcare,
UAE
Scientific Committee Member
Consultant Pathologist and Cytopathologist
Director of Cytology
Department of Pathology
American Hospital Dubai
UAE
Dr. Yasin K Ahmed is a Pathologist and Cytopathologist, certified by Anatomic Pathology Board, Clinical Pathology Board and the Cyptopathology Board. He has expertise in Surgical Pathology, Oncologic Pathology, Fine Needle Aspiration and Cyptopathology. He completed his residency at the St. John Hospital, an affiliate hospital of Wayne State University where he also served as Chief Resident. He also completed advanced fellowship training at prestigious academic institutions in the United States including Memorial Sloan Kettering Cancer Center and MD Anderson Cancer center and Wayne State University. He has extensive experience and has worked as Attending Pathologist at the Quest Diagnostic/Ameripath, USA.
Scientific Committee Member
Consultant Anatomic Pathologist, Division Head of Image and Laboratory
H.H. Sheikh Khalifa Specialty Hospital
UAE
MD, FRCPath, CCT (UK)
Scientific Committee Member,
Consultant Anatomic Pathologist,
Anatomic Pathology and Cytopatholo,
Medical Affairs, Tawam Hospital
UAE
Scientific Committee Member
Assistant Professor of Pathology and Consultant Histopathologist, Department of Pathology
Mohamed Bin Rashid University of Medicine and Health Sciences
UAE
Scientific Committee Member
Consultant Anatomic Pathologist, Department of Pathology and Laboratory Medicine Mediclinic
UAE
M.D., FCAP, DipABLM
Scientific Committee Member
Consultant, Anatomic Pathologist & Cytopathologist
Medical Director, e-Pathology Program
Clinical Professor of Pathology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland Clinic Abu Dhabi
UAE
Consultant, Division of Anatomic Pathology
Professor of Pathology
Mayo Clinic
Dr. Torbenson is a Professor of Pathology at Mayo Clinic, Rochester, where he specializes in GI and liver Pathology. He has authored over 250 papers. In these papers, he has described several new pathology entities as well as several new tumor subtypes. Dr. Torbenson has authored numerous book chapters, and five books on liver pathology, including a book on liver biopsy interpretation, a book on tumors of the liver, and a comprehensive liver pathology textbook. He is an author on the AFIP liver tumor Fascicle and author on the HCC chapters for the past two editions of the WHO blue books on GI and liver tumors.
Dr. Torbenson has been president of the Hans Popper Hepatobiliary Pathology Society and is current president of the Roger C Haggitt Society for GI pathology (GIPS).
Dr. Torbenson grew up in Minnesota, but trained at the University of Pittsburgh Medical Center for both residency and for a fellowship in liver and transplant pathology, followed by a GI pathology fellowship at Johns Hopkins. He stayed on as faculty at Johns Hopkins until 2013, when he returned to Minnesota and joined Mayo Clinic Rochester.
Department of Pathology and Laboratory Medicine
King Faisal Specialist Hospital and Research Centre
Saudi Arabia
Professor & Chair
University of Louisville Department of Pathology & Laboratory Medicine
USA
Eyas M. Hattab, MD, MBA, FCAP, is the AJ Miller endowed Professor and Chair of Pathology and Laboratory Medicine at University of Louisville. Dr. Hattab obtained his medical education from Jordan University of Science and Technology before embarking on a residency in Anatomic and Clinical Pathology at the University of Florida, Jacksonville where he also served as Chief Resident. He then completed Neuropathology Fellowship training at Stanford University followed by an Oncological Surgical Pathology Fellowship at the Ackerman Laboratory of Surgical Pathology at Barnes-Jewish Hospital/Washington University. Dr. Hattab is an internationally recognized surgical neuropathologist and a frequent invited speaker with expertise in the study of brain cancer and the characterization of its morphologic, immunohistological, and molecular features. His clinical practice also includes ophthalmic pathology, transplant pathology and immunohistochemistry. He has over 100 peer-reviewed publications and book chapters to his credit and serves on several national committees governing the field of Neuropathology, including the College of American Pathologists Neuropathology and Diffuse Glioma Committees, the CAP Cancer Biomarker Reporting Committee (CBRC) CNS panel, International Collaboration on Cancer Reporting (ICCR), and the Lower Grade Gliomas Disease Working Group of The Cancer Genome Atlas (TCGA) project, the National Cancer Institute. In addition, Dr. Hattab holds a Business of Medicine Master of Business Administration degree from the Kelley School of Business at Indiana University.
Professor of Pathology and Chief of Breast Pathology
New York Presbyterian Hospital and Weill Cornell Medical College, New York, NY
USA
Dr. Syed Hoda is a diagnostic surgical pathologist with a particular interest in breast pathology. Dr. Hoda graduated at the top of his class from Dow Medical College, Karachi. He trained in anatomical and clinical pathology at Tulane University Affiliated Hospitals in New Orleans, LA (1985-1990). Subsequently, he underwent subspecialty fellowship training in Cytopathology at Memorial Sloan-Kettering Cancer Center in New York, NY (1990-91); and another year of subspecialty fellowship training in oncological surgical pathology at Memorial Sloan-Kettering Cancer Center with Drs. Juan Rosai and Paul Peter Rosen. Dr. Hoda has been associated with Weill Cornell Medical College and New York Presbyterian Hospital-Weill Cornell Medical College since 1992. He is certified by the American Board of Pathology in Anatomical Pathology, Clinical Pathology and Cytopathology. He has co-authored four books: Rosen's Breast Pathology (latest edition in December 2020), Rosen's Breast Pathology: Diagnosis by Needle Core Biopsy (multiple editions), Liquid Based Cytology, and The Pap Test. He has contributed over 250 publications in peer-reviewed journals, and is on the Editorial Board of Advances in Anatomic Pathology, American Journal of Clinical Pathology, American Journal of Surgical Pathology, International Journal of Surgical Pathology, and The Breast Journal. Dr. Hoda is active on the regional, national and international lecture circuit.
Staff Pathologist
CBLPATH Inc.
USA
Dr. Rana S. Hoda is board certified in Anatomic Pathology and Cytopathology by the American Board of Pathology. Her primary clinical focus is cytopathology with special expertise in fine needle aspiration, urinary and liquid based cytology. She trained in Anatomic Pathology at Cornell University Medical College-affiliated Hospitals. Subsequently, she underwent a fellowship in Oncologic Surgical Pathology at Memorial Sloan- Kettering Cancer Center, New York, NY with several outstanding oncological pathologists including Drs. Juan Rosai and Paul Peter Rosen. The following year, she did a fellowship in Cytopathology at Montefiore Medical Center - Albert Einstein College of Medicine, New York, NY under the guidance of Dr. Leopold G. Koss, one of the pioneers of cytopathology. She served as a Lecturer of Pathology at the Hospital of University of Pennsylvania at Philadelphia. Following this, she served as Assistant, Associate and Professor of Pathology, Director of Cytopathology and Director of Cytopathology Fellowship Training Program at three major academic centers including Medical University of South Carolina (MUSC) at Charleston, University of Rochester and Weill Cornell Medical College (WCMC)-New York Presbyterian Hospital.
Dr. Hoda has published more than 100 scientific papers, several chapters and three text books including books on urinary cytology and liquid-based preparations. She is on the editorial board of several cytopathology journals including Diagnostic Cytopathology, Journal of American Society of Cytopathology and Cytojournal. Dr. Hoda directed annual cytopathology educational conferences at MUSC and WCMC from 2000-2016. She is active on the regional, national and international lecture circuit. She continues to lecture at various pathology meetings; including American Society of Cytopathology (ASC), United States & Canadian Academy of Pathology (USCAP), American Society of Clinical Pathologists (ASCP), College of American Pathologists (CAP) and International Academy of Cytopathology; and has participated in educational conferences in several countries. Dr. Hoda is an active member of ASC, USCAP, ASCP, CAP and the New York Pathological Society.
Anil Parwani, M.D., Ph.D., M.B.A.
Professor of Pathology and Biomedical Informatics
Director, Digital Pathology Shared Resources
Principle Investigator, Cooperative Human Tissue Network (CHTN) Midwestern Division
Wexner Medical Center - Department of Pathology
USA
Dr. Anil Parwani is a Professor of Pathology at The Ohio State University. He serves as the Vice Chair and Director of Anatomical Pathology. Dr. Parwani is also the Director of Pathology Informatics and Director of the Digital Pathology Shared Resource at The James Cancer Hospital. His research is focused on diagnostic and prognostic markers in bladder and prostate cancer, and molecular classification of renal cell carcinoma. Dr. Parwani has expertise in the area of surgical pathology, viral vaccines and immunology, and pathology informatics including designing quality assurance tools, bio banking informatics, clinical and research data integration, applications of whole slide imaging, digital imaging, telepathology, image analysis and lab automation. Dr. Parwani has authored over 300 peer-reviewed articles in major scientific journals and several books and book chapters. Dr. Parwani is the Editor-in-chief of Diagnostic Pathology and one of the Editors of the Journal of Pathology Informatics.
Mayo Clinic
USA
Mayo Clinic
USA
Mayo Clinic
USA
Consultant Pathologist
Sheikh Khalifa Specialty Hospital (SKSH)
UAE
Hyo Jin Park, M.D., Ph.D. is a consultant pathologist at Sheikh Khalifa Specialty Hospital (SKSH). She is affiliated at Seoul National University (SNU) Hospital in Korea as a clinical assistant professor. Dr. Park received M.D. degree from SNU, College of Medicine in 1998 and her Ph.D. from SNU, College of Medicine in 2010 with the thesis of “T cell development in genetically engineered mouse”. After undertaking an internship at SNU Hospital, she did her residency in pathology at the same hospital. From 2011, as a clinical assistant professor in Pathology Department of SNU Bundang Hospital, her research and clinical activity focused on endocrine, bone/soft tissue pathology, immunology and molecular pathology. She has worked at SKSH, Pathology department from 2015 in which genetic test on solid tumor using next generation sequencing was implemented successfully under supervision of her. She has published many articles in SCI journals.
Associate Professor of Pathology
Consultant Histopathologist
Clinical Sciences Department, College of Medicine
University of Sharjah
UAE
Graduated from Faculty of Medicine, Alexandria University, Egypt, with a MSc and PhD in Basic Medical Sciences in Pathology. Joined the Pathology Department, Alexandria Faculty of Medicine in 1999, and maintains a faculty appointment as Full Professor of Pathology since 2018. Appointed as an Associate Professor in Clinical Sciences Department, College of Medicine, University of Sharjah, UAE since 2016. A consultant histopathologist with a primary interest in general surgical pathology and a special interest in breast, GIT and renal pathology. Her research work in the field of cancer, focusing mainly on breast, colorectal, prostate and renal cancer. She has a good experience in immunohistochemistry (IHC), in-situ hybridization (ISH) and fluorescence in situ hybridization (FISH). She has publications in different national and international peer reviewed journals. She is also the PI and co-PI of different internal and external grants awarded for cancer research.
Consultant Histopathologist & Head of Cytology Unit
Pathology and Genetics Department
Clinical Support Services Sector
Dubai Hospital, UAE
Dr Manal Abdulrahim received her primary medical degree from the Royal College of Surgeons in Ireland in 2001. She trained in Histopathology in Ireland and joined the Munster Histopathology Training Scheme; where she completed her Fellowship of the Royal College of Pathologists in Histopathology (FRCPath) and achieved the certificated of satisfactory completion of specialised training in histopathology (CSCST) in 2008. She is appointed as a Consultant Histopathologist at Dubai Hospital since 2009 and is the Head of the Cytology Unit. Her special area of interest is Breast Pathology.
Consultant Physician
Physician-Laboratory Medicine Services
Sheikh Shakhbout Medical City
UAE
Dr. Rawia graduated from King Abdul-Aziz University in Jeddah –Saudi Arabia in 2004. She did her Anatomical pathology residency in Prince of Wales Hospital. She was also a clinical tutor in the Chinese University of Hong Kong (2007-2011) and was a tutor in the Royal College of surgeons of Ireland (RCSI) (2011-2015).
She got her Australian fellowship (FRCPA) in Anatomical pathology in 2011. She did her neuropathology fellowship in Prince of Wales Hospital with Prof. HK.NG
Dr Rawia working as consultant pathologist and neuropathologist since 2011. Dr. Rawia Handling both surgical and cytology specimens. Currently she is working at Sheikh Shakhbout medical city in partnership with Mayo clinic.
Dr. Rawia is a speaker in multiple national and international conferences and she has multiple publications in her field.
Specialist Physician
Department of Laboratory Medicine
Sheikh Khalifa Specialty Hospital, RAK, U.A.E.
Dr Joowon Oh was born and raised in South Korea. She received her B.Sc. degree (Economics) from Seoul National University, Medical Doctor degree from Ewha Women’s University and Ph.D. from Yonsei college of Medicine, Yonsei University.
Dr Oh was trained as Resident in Department of Laboratory Medicine in Severance hospital, Yonsei University. She developed her interest in molecular diagnostics during the residency and pursued Ph.D in Medicine, Speciality in Genetics. After achieving board in Laboratory Medicine, she worked as fellow for 1 year and Clinical Assistant Research Professor for 1 year in Gangnam Severance Hospital, Yonsei University.
On April, 2020, in the middle of COVID pandemic, she joined Sheikh Khalifa Specialty Hospital, UAE. Since the beginning of the work in SKSH, she has led two successful ISO accreditation, kept up with good performance in KPI assessment and managed molecular diagnostics both human and microbiology.
Dr Oh is an active researcher, educator and physician.
Consultant Anatomical Pathologist
National Reference Laboratory (NRL)/ Cleveland Clinic Abu Dhabi (CCAD),
Abu Dhabi, UAE
MBChB, MRCS (UK), FRCPath (UK), CCT (UK), PGCert Med Ed.
Currently Dr Quadri is a Consultant Anatomical Pathologist at CCAD/NRL, and is one of the team for gynecological pathology service. Prior to this he was Chief of AP Service and lead pathologist for the Gyn-oncology tumor board at the regional Cancer Centre Tawam Hospital, UAE (Aug 2013-Sept 2020).
Dr Quadri was working as a Consultant for five years in Birmingham, UK, at the Pan-Birmingham gynae-oncology center – City Hospital, between 2008 and 2013.
He held position of Chief of Service for Anatomical Pathology at Tawam Hospital and also lead on Oncological testing development.
His interests include Gynecological Pathology, Lung / Thoracic pathology, Breast and GI pathology. His Gyne pathology interest led him to spend extra 3 months in Birmingham Women’ Hospital, UK, as a senior resident. He obtained the fellowship from Royal College of Pathologists (FRCPath) in London in 2008 and Certificate of Completion of Training (CCT) in early 2009. Dr Quadri obtained a Post Graduate Certificate in Medical Education with merit from Staffordshire University, UK, in 2013. Currently he is a member of the cervical cancer task force at DOH, UAE, and also holds Adjunct Prof. title at CMHS UAE University, Al Ain.
His passions include “Quality”, and he is a qualified inspection team member for College of American Pathologist lab accreditation inspections.
He also is a current examiner for the FRCPath final exam for UK and Middle East.
Director, Genomics Center,
Al Jalila Children's Specialty Hospital
Associate Professor of Genetics,
Mohammed Bin Rashid University of Medicine and Health Sciences
Dr. Ahmad is the Director of the Genomics Center at Al Jalila Children's, and an Associate Professor of Genetics at Mohammed Bin Rashid University of Medicine and Health Sciences. He completed his doctoral studies in genetics at Dartmouth College, followed by a fellowship in molecular diagnostics at Dartmouth Medical School. In 2013, he joined Harvard Medical School where he completed his clinical molecular genetics fellowship and, in 2015, became board-certified by the American Board of Medical Genetics and Genomics (ABMGG). Dr. Abou Tayoun is a fellow of the American College of Medical Genetics and Genomics. Prior to joining Al Jalila Children's, he was a director in the Division of Genomic Diagnostics at the Children's Hospital of Philadelphia, and also an assistant professor of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine.
To support clinicians in various specialties at CHOP, Dr. Ahmad developed genomic sequencing-based diagnostic tests for a range of pediatric disorders. He also developed and published several tools and clinical assays involving next-generation sequencing and variant interpretation. Dr. Abou Tayoun serves on several international expert groups in his field. He is a co-chair of the Clinical Genome Resource (ClinGen) Hearing Loss Expert Group, a member of the ClinGen Sequence Variant Interpretation group, and also a member of American College of Genetics and Genomics Interpreting Sequence Variants workgroup. In those capacities, Dr. Abou Tayoun is working with international experts to establish guidelines and recommendations for sequence variant interpretation in genomic diagnostic settings.
Dr. Abou Tayoun's main research interests are centered around characterizing the genomic landscape of pediatric diseases in the Middle East, and cataloguing the normal genetic variation in this population. In addition, he is one of the leaders in driving national efforts to characterize the epidemiological and genomic characteristics of SARS-CoV-2 in the UAE, and to identify host genetics factors and RNA expression profiles modulating COVID-19 disease severity.
Associate Consultant
Department of Anatomical Pathology
Singapore General Hospital
Singapore
Dr Loh Jiezhen Tracy is currently a Consultant pathologist Department of Anatomical Pathology, Division of Pathology, Singapore General Hospital. She graduated from the Faculty of Medicine, National University of Singapore in 2009 and did her Pathology residency training with Singhealth, with rotations through Singapore General Hospital, Changi General Hospital, KK Women’s and Children’s Hospital and Health Sciences Authority before exiting training to work in Singapore General Hospital. Her interests are in gastrointestinal and hepatopancreatobiliary pathology.
In addition to continuing to improve her diagnostic skills, she hopes also to be able to contribute and teach the next generation of pathologists.
Emirate Neuropathologist
Member of the German Society of Neuropathology and Neuroanatomy (DGNN)
Interested in Moleculer diagnostic of Brain tumor,
Forensic Neuropathology CSF
Ibrahim Yaseen Hachim
Assistant Professor in Pathology
Sharjah, United Arab Emirates
Dr. Ibrahim Yaseen Hachim is Assistant Professor in Pathology, College of Medicine, Department of Clinical Sciences, Sharjah university. Dr. Ibrahim is a medical doctor with M.Sc. in histopathology. He obtained his Ph.D. from Cancer Research Program, College of Medicine, McGill University, Montreal, Canada.
Dr. Hachim is known for his research work in the field of molecular pathology. His research interest includes. molecular pathology.
Dr. Ibrahim had more than 40 publications in different prestigious journals. During his career, Dr. Ibrahim received several awards including two doctoral scholarships, two Graduate Excellence Award, George G. Harris Fellowship in Cancer, McGill University, Montreal, Canada. In addition, to Pauline Blinder Krupp Award for the most promising clinical researchers in Montreal, Canada.
Director of Digital Pathology
Department of Pathology
Kameda Medical Center
Japan
Dr. Bychkov is originally from Russia, where he obtained his MD and practiced in anatomic pathology. Later, he earned a PhD in molecular medicine in Nagasaki, Japan.
His subspecialty is thyroid pathology and he has contributed to the WHO classifications of endocrine tumors (2021) and hematolymphoid tumors (2022).
Currently, he is tasked with overseeing digital pathology initiatives in Japan. Dr. Bychkov and his team are pioneers of digital pathology in Asia and their ongoing mission is to educate about benefits of digital pathology and how to implement digital pathology and AI.
Dr. Bychkov is a deputy editor for PathologyOutlines and academic editor for several international journals. He has authored over 90 journal articles and book chapters. He regularly presents at various conferences and pathology meetings, including top-ranked events.
Chair/professor
Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences
Nagasaki University Faculty of Medicine
Japan
Dr. Junya Fukuoka is a practicing pathologist who has expertise in the field of lung pathology and digital pathology. He is currently a chair of pathology committee at the research group associated with Japanese Society of Respirology and an official consultant of Japanese Society of Pathology in the field of non-neoplastic lung diseases. He is also a president of The Japanese Society of Digital Pathology that has more than 20 years of history. He is a great teacher and mentoring more than a hundred of students and fellows inside Japan. He has a strong passion to develop educational center for pathologists in Japan.
Professor in Dermatology and Pathology
Northwell Health, New York
USA
Dr. Singh is a Professor in Dermatology and Pathology at Northwell Health, New York. He directs the Dermatopathology Section and is the Associate Chair of Digital Pathology. He is the Founder of PathPresenter, an online digital platform that has 400,000+ users in 190+ countries and is used by multiple academic departments, private pathology groups and organizations in the US and all over the world. (https://pathpresenter.ai/) Dr. Singh has served as the Chair of the American Society of Dermatopathology Informatics Committee. He currently serves on the Sulzberger Grant Committee of the AAD and on the Editorial Board of JAAD. He is the Editor, creator and developer of the app, mydermpath+ and educational platforms-wiydx.com. He also serves as a member of the Editorial Board of the WHO for Classification of tumors, 5th Edition and the Board of Digital Pathology Association. He was nominated to the Pathologist Power List 2020 and 2021.
